Mehul Kothari recommends Biocon, Aurobindo Pharma for trading gains

According to the technical analyst from Anand Rathi, Aurobindo Pharma can rally to Rs 490; while Biocon can jump to Rs 295.

Pharmacy
Photo: Shutterstock
Mehul Kothari Mumbai
1 min read Last Updated : Dec 23 2022 | 8:11 AM IST
BUY
Aurobindo Pharma
Buy Near: Rs 445
Target: Rs 490
Stop Loss: Rs 430

Aurobindo Pharma has found support at the placement of 200 bars moving average and that too on a monthly scale. This means 200 months average and that can be a huge support. Thus, we advise traders to buy the stock on dips near Rs 445 with a strict stop of Rs 430.

Also Read


BUY
Biocon
Buy Near: Rs 270
Target: Rs 295
Stop Loss: Rs 257

We are witnessing a double bottom formation near Rs 257. In addition there is a bullish hammer kind of formation on the daily scale. Thus, we advise traders to buy the stock on dips near Rs 270 with a strict stop of Rs 257.

(Mehul Kothari - AVP – Technical Research, Anand Rathi Shares & Stock Brokers. Views are personal).
 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Market technicalsBioconAurobindo Pharmastocks technical analysistechnical chartsPharma stocksstock market trading

Next Story